http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004080378-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_32f708c06c41fb465fb25325f69c73f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b8b1e47ccb17e121e9a072a8a41dbf1e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6a1554706492f1e40c1e30a8a82d40b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6811
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
filingDate 2004-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34f831bc018c68cc956813b4e1c49b0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2519c2a2147b9c94c991671515ca104b
publicationDate 2004-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2004080378-A2
titleOfInvention Methods and tools for screening active rna in cellulo
abstract The invention relates to methods and compositions for screening active RNA in cellulo. The invention more particularly relates to methods for the preparation and selection of random RNA providing a cell with a desired phenotype, random RNA banks and the production thereof, in addition to cellular populations which are transformed by said banks. The invention further relates to active RNA identified for the purpose of research or for therapeutical reasons in order to induce a desired phenotype in a cell in vitro, ex vivo or in vivo, more particularly in human cells.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005073380-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005073380-A2
priorityDate 2003-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9832880-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03022311-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9941371-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128074998
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136301090
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54684461
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54685767
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439530
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395360
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399415
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395361
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395404
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399416
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9956178
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395405
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54740249
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44259

Total number of triples: 35.